by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
The Global Clinical Trials Market reached USD 56 640 7 million in 2022 and is projected to witness lucrative growth by reaching up to USD 99 212 0 million by 2031 The clinical trials market is expected to exhibit a … The Global Clinical Trials Market reached...
by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic cancer respond to immunotherapies. Researchers have discovered race-associated molecular differences in tumors that may impact the way...
by palligoelme@gmail.com | Mar 13, 2025 | Clinical Trials
Li-Yuan Bai, M.D., M.M.S., Ph.D. Li-Yuan Bai, M.D., M.M.S., Ph.D.
by palligoelme@gmail.com | Mar 12, 2025 | Clinical Trials
/PRNewswire/ — GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for… /PRNewswire/ — GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced...
by palligoelme@gmail.com | Mar 12, 2025 | Uncategorized
LaShell Robinson, head of global feasibility and trial equity at Takeda explains how the company’s Phase 3 trial for a psoriasis drug ended enrollment well before it’s goal and achieved some impressive diversity metrics.
